Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

July 12, 2023

Study Completion Date

July 12, 2023

Conditions
Parkinson DiseaseEffect of Drug
Interventions
DRUG

Hypoxic Gas Mixture

Using a commercially available hypoxicator, varying gas mixtures as described will be administered via a tight-fitting oxygen mask. In the circuitry, a three-way valve is placed that allows for the intermittent administration of hypoxia: the valve either passes the hypoxic mixture from the hypoxicator or room air.

Trial Locations (1)

6525EX

Dpt. of Physiology, Radboud University Medical Center, Nijmegen

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Radboud University Medical Center

OTHER